Pheochromocytoma
ICD-10 E27.5 · ICD-11 5A75

What Is the Preoperative Treatment of Pheochromocytoma?

Clinical Scenario

Hormonally functional pheochromocytoma or paraganglioma (PPGL) scheduled for surgical resection. Catecholamine excess creates severe perioperative cardiovascular risk; structured preoperative preparation is required before the tumour can be safely removed.

Treatment Approach (summary)

All patients with a hormonally functional PPGL require a preoperative blockade course, typically running 7 to 14 days before surgery. The protocol specifies a preferred first-line class of adrenergic blocker, conditions under which a second class may be added, and mandatory volume repletion measures to counteract the haemodynamic effects of catecholamine excess.

Agent selection, sequencing, and the full preparation algorithm are available in the complete protocol below.

Haemodynamic Targets
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1210/jc.2014-1498

We recommend that all patients with a hormonally functional PPGL should undergo preoperative blockade to prevent perioperative cardiovascular complications.

We suggest α-adrenergic receptor blockers as the first choice.

We recommend preoperative medical treatment for 7 to 14 days to allow adequate time to normalize blood pressure and heart rate.

Treatment should also include a high-sodium diet and fluid intake to reverse catecholamine-induced blood volume contraction preoperatively to prevent severe hypotension after tumor removal.

Preoperative coadministration of β-adrenergic receptor blockers is indicated to control tachycardia only after administration of α-adrenergic receptor blockers.

Based on retrospective studies and institutional experience, a target blood pressure of less than 130/80 mm Hg while seated and greater than 90 mm Hg systolic while standing seems reasonable, with a target heart rate of 60–70 bpm seated and 70–80 bpm standing.

View source ↗